Behavioral Health Outcome Studies
The Family Educational Rights and Privacy Act (FERPA)
Shanna Babalonis, Ph.D.
Shanna Babalonis, Ph.D.
Dr. Babalonis completed her doctoral research in behavioral neuroscience and psychopharmacology at the University of Kentucky in 2010, with this research being supported by an NIH R36 Dissertation Award. She completed her postdoctoral research fellowship under the mentorship of Drs. Sharon Walsh and Michelle Lofwall and is now an Assistant Professor, Research Title Series in the Department of Behavioral Science and Center on Drug and Alcohol Research at the University of Kentucky. She is also a current KL2 Research Scholar (supported by the UK Center for Clinical and Translational Science). Her research interests include conducting carefully controlled human laboratory studies to assess abuse liability and relative potency of opioid analgesics and to evaluate novel treatments for substance abuse. Dr. Babalonis is currently working on several NIH-funded projects including a clinical trial investigating a novel treatment for marijuana dependence, and several laboratory-based studies that examine the pharmacokinetics of novel tracers for medication adherence, the influence of a cannabinoid-based drug on the reinforcing effects of smoked marijuana, and the effects of widely prescribed/frequently abused medications on simulated driving performance. Dr. Babalonis is also a current recipient of the NIH Loan Repayment Award.
Representative Peer-Reviewed Manuscripts:
Babalonis S, Lofwall MR, Nuzzo PA & Walsh SL (2014). Pharmacodynamic effects of oral oxymorphone: Abuse liability, analgesic profile and direct physiological effects in humans. Addiction Biology, in press.
Lofwall MR, Babalonis S, Nuzzo PA, Siegel AJ, Campbell C & Walsh SL (2013). Efficacy of extended-release tramadol for the treatment of prescription opioid withdrawal: A two-phase randomized controlled trial. Drug and Alcohol Dependence, 133(1): 188-97.
Babalonis S, Lofwall MR, Siegel AJ, Nuzzo PA & Walsh SL (2013). Relative abuse liability and reinforcing efficacy of oral tramadol in humans. Drug and Alcohol Dependence, 129(1-2):116-24.
Babalonis S, Lile JA, Martin CA & Kelly TH (2011). Separate and combined effects of progesterone and triazolam in healthy, premenopausal women. Psychopharmacology, 215(3): 429-39.
Babalonis S, Lile JA, Martin CA & Kelly TH (2011). Progesterone modulation of the discriminative stimulus, subjective and performance effects of triazolam in healthy, pre-menopausal women. Behavioural Pharmacology, 22(5-6): 441-9.
Babalonis S, Lile JA, Martin CA & Kelly TH (2008). Discriminative Stimulus Effects of Triazolam as a Function of Menstrual Cycle Phase. Drug and Alcohol Dependence, 94(1-3), 276-280.
|Give to Medicine | Privacy | Jobs | News | Directions | UK Home | UK Medical Center|
© 2014, University of Kentucky College of Medicine, 800 Rose St., Lexington, Kentucky, USA 40536-0298, Phone (859) 323-5000
Please send us Comments and Corrections | An Equal Opportunity University | Terms, Conditions & Privacy and Accessibility Statements
Page last updated Friday, July 18, 2014